ProCare Rx - History ProCare Rx founded as a Healthcare Information Technology Company

Similar documents
Understanding Pharmacy Benefit Management Services

PHARMACY BENEFIT MANAGER (PBM)

Pharmacy Benefit Managers Overview

WorldatWork You and Your PBM: Improving Discounts, Fees and Rebates, and Beyond. Kristin Begley, Pharm.D. Principal

Moving From PBM to PBA Model

Plunging into PBM Pricing Spread to Create Client Centric Contracts

Pharmacy Benefit Strategies for Lowering Prescription Drug Costs

What to Expect for Pharmacy Benefits and Drug Cost Trends for 2018 & 2019

Get the most out of your pharmacy benefit.

Pharmacy Benefit Strategies for Lowering Prescription Drug Costs

Investor Conference. Health Net Pharmaceutical Services

SelectHealth Prescriptions

Best Practice Recommendation for

THANK YOU SPONSORS 2

Pharmacy Benefit Strategies for Lowering. Prescription Drug Costs

Pharmacy Program Management: Pitfalls, Challenges, and Best Practices About Solid Benefit Guidance specialty 60,000,000 covered member lives INSIDER

Lindsey Imada, PharmD Candidate 2016 Midwestern University, Chicago College of Pharmacy

I. PURPOSE. A. The primary objectives of Molina Healthcare s Transition Policy and Procedure are:

Glossary of Terms (Terms are listed in Alphabetical Order)

2015 PacificSource Medicare Part D Transition Process for contracts H3864 & H4754:

Contract Summary. OptumRx Administrative Services, LLC

THE GENERAL ASSEMBLY OF PENNSYLVANIA SENATE BILL INTRODUCED BY EICHELBERGER, ARGALL, RAFFERTY, VULAKOVICH AND BROWNE, MAY 18, 2018 AN ACT

Pharmacy Benefit Managers (PBMs)

The U.S. Healthcare System: How Pharmacy Benefit Managers Impact Prescription Drug Use. Presented by Daniel Tomaszewski Pharmd, PhD

Contract Summary. OptumRx Administrative Services, LLC

Pharmacy Trend Management

Latest Trends Collective Bargaining and Healthcare Strategies for Public Entities. March 10, 2016

The Real-Time Benefit Check Key to Closing the Gaps in Eligibility Driven Formulary. Tony Schueth Chief Executive Officer & Managing Partner

White Paper: Formulary Development at Express Scripts

Harvard Pilgrim Health Care Pharmacy Services Policy & Criteria. Medicare Advantage Transition of Care

Understanding Your Prescription Program. CCIU Employee Meeting September 7, 2016

KEEPING PRESCRIPTION DRUGS AFFORDABLE: The Value of Pharmacy Benefit Managers (PBMs)

Medicare Part D Transition Policy CY 2018 HCSC Medicare Part D

21 - Pharmacy Services

Pharmacy Benefit Management in Oncology

Access, Quality & Transparency: The Forgotten Issues in the Healthcare Debate Presented at WCIF Benefits Summit April 19, 2017

Harvard Pilgrim Health Care Pharmacy Services Policy & Criteria. Medicare Advantage Transition of Care

Y0076_ALL Trans Pol

DIR: Trends, Issues, and Impending Impacts

PURPOSE OF THE POLICY STATEMENT OF THE POLICY PROCEDURES

2019 Transition Policy

!"#$% &!'()*+$",-."%%%)$% &!'()*+$ What are PBMs?

UC SHIP Premium Formulary. Effective September 1, 2016

A Better Way to Navigate the Complex World of Pharmacy Benefits. Pharmacy Purchasing Coalition

All Medicare Advantage Products with Part D Benefits

We applied the following methodology and assumptions changes to our original estimates:

Prescription Drugs Spending Distribution and Cost Drivers. Steve Kappel January 25, 2007

THIRD-PARTY PHARMACY RECONCILIATION

Community Care, Inc. Medicare Part-D Enrollee Transition Plans H5212 PACE and H2034 HMO-SNP 2018

CIS Responses to Vendor Questions PBM RFP September 23, 2015 Addendum #1

Martin s Point Generations Advantage Policy and Procedure Form

TouchScript Medication Management System. Financial Impact Analysis on Pharmacy Risk Pools

Subject: Pharmacy Services & Formulary Management (Page 1 of 5)

Innovative Strategies for Managing the Rising Cost of Specialty Drugs

Workers Compensation Board Pharmacy Benefit Plan

Survey Analysis of January 2014 CMS Medicare Part D Proposed Rule

Pharmacy Billing and Reimbursement

Prescription Drug Benefit Plans: A Buyer s Guide. chcf

The Pros and Cons of Self-Funding Health Coverage

2012 Medicare Part D Transition Process for contracts H3864 & H4754:

Understanding PBM Quality. The 2 nd National Alliance PBM Report. John Miller

BERKELEY RESEARCH GROUP. Executive Summary

LEGISLATURE 2017 BILL. reporting by manufacturers and providing a penalty.

Summary of Benefits. Aetna Medicare Rx Costco Plus Plan (PDP) S5810. California. January 1, 2010 to December 31, 2010

PRESCRIPTION DRUG SPENDING IN THE U.S. HEALTH CARE SYSTEM: AN ACTUARIAL PERSPECTIVE

INDUSTRY PERSPECTIVE. Quick Reference Data Current as of July 2015

2016 Drug Trend Report Executive Summary

Managed Care Pharmacy Commercial Perspective

Overview of the BCBSRI Prescription Management Program

Mini-Summit III: Insurance Benefit Design and Cost Sharing for Payment Reforms

Cherokee Nation Businesses, LLC. Request for Proposal. For Pharmacy Audit

Prescription Drug Coverage

Source Rx. Pharmacy Benefits Management

PHARMACY BENEFITS MANAGER SELECTION FAQ FOR PRODUCERS

MESSA Saver Rx PRESCRIPTION DRUG RIDER BOOKLET

Innovative Prescription Drug Management from Great-West Life

Innovative Prescription Drug Management from Great-West Life

San Francisco Health Service System Health Service Board

Presented January 20 th by Pharmacy Healthcare Solu7ons, Inc. Don Dietz, R.Ph, MS, Vice President

CWAG Prescription Drug Pricing Webinar

Insights into pharmacy benefit management, drug trend and the future

How ACO s Can Impact Contracting A Real World Example. Mike Medel Pharm D, MBA Banner Health

Today PBMs control the pharmacy benefits of more than 253 MILLION Americans.

Today PBMs control the pharmacy benefits of more than 253 MILLION. 3 PBMs. Americans.

Steve Liles, PharmD Senior Director, Value Based Purchasing Magellan Medicaid Administration

Putting the Pieces Together, a Review of the Benefits Investigation Process. Thomas Cohn, Asembia

Medicare Congress: Fee for Service Trends: A Look at Medicare Part B

Medicare Part D Prescription Drug Plan

Texas Vendor Drug Program. Drug Addition Process. Effective Date. December 2017

2018 Medicare Part D Transition Policy

NCPDP Electronic Prescribing Standards

Jill Rosenthal, MD, MA, MPH, FACOEM SVP, Chief Medical Officer Zenith Insurance Company

Chapter 17: Pharmacy and Drug Formulary

NEGATIVE CONSEQUENCES OF THE OHIO PRESCRIPTION DRUG (or Rx) BALLOT ISSUE Families & Children in Medicaid, Pharmacy Services Are Impacted

Medicare Advantage Part D Pharmacy Policy

Prescription Drug Pricing and Community Pharmacy NALEO Legislative Summit on Health October 21, 2017

Introduction to the US Health Care System. What the Business Development Professional Should Know

Medicare Part D Transition Policy

The People of the State of New York, by their attorney, Eliot Spitzer, Attorney General of

How the Blueprint Policy Statement to Lower Drug Costs and Reduce Out-of- Pocket Costs May Affect Employers

Transcription:

ProCare Rx - History 1988 ProCare Rx founded as a Healthcare Information Technology Company 1996 Pharmacy Internet Switching Released 2003 ProCare Pharmacy Care Mail Order & Specialty Pharmacy Established 2014 Western HQ Las Vegas Opened 2016 HST Pharmacy Established 1994 Claims Processor Released 2000 PBM Established 2006 ProCare HospiceCare PBM Division Established 2015 ProMod Rx Established

Traditional Model vs. Pass-Through Model Traditional Model: PBM makes money through spread pricing (difference between what PBM pays pharmacy and what PBM bills client) PBM pays pharmacy $100.00 and bills client $113.00 NO administration fee charged to client Client pays $113.00 PBM profit is $13.00 Pass-Through Model: PBM makes money through administration fee PBM pays pharmacy $100.00 and bills client $100.00 $4.00 administration fee charged to client Client pays $100.00 plus a transparent $4.00 administration fee = $104.00 PBM profit = $4.00

AWP Discounts Average Wholesale Price (AWP) AWP discounts have become meaningless in traditional spread models Game of definitions: brands, high-priced generics, single source generics, etc. PBM guarantees a brand discount rate of AWP -18.5% PBM guarantees a generic discount rate of AWP -84% Pass-Through PBMs guarantee to pass through their true discounts!

What Happens Brands Single Source Generics High Priced Generics Low Priced Generics AWP -16.5% AWP -30% AWP -60% AWP -84% AWP -18.5% Middle 2 pushed left Spread models push left AWP -84% AWP -16.5% Middle 2 pushed right Pass-through follow RFP directions even though 4 distinct columns AWP -78% The Spreadsheet Game

Payers Problem Traditional PBMs look better on paper (i.e. the spreadsheet) What happens if you put your worst priced generics into the brand bucket? Including single source generics and certain high priced generics in brand bucket will artificially improve brand discount rate Moving these same drugs to the brand discount bucket also artificially inflates the generic discount rate After hundreds of repricings, it is very clear Payers consistently pay more by using the spread model

The Spreadsheet Traditional (Spread) Model Brands: AWP -18.5% Generics: AWP -84% Dispensing Fee: $0.50 Admin Fee: $0.00 Broker Fee: $0.00 Pass-Through Model Brands: AWP -16.5% Generics: AWP -78% Dispensing Fee: $1.40 Admin Fee: $2.75 Broker Fee: $0.75

Actual Repricing Data: Same Drug, Same Pharmacy, Same Day Traditional (Spread) Model Net Rx Claims: 24,368 Ingredient Cost: $2,992,448 Spread: $324,716 $324,716/24,368 = $13.32 ProCare Rx (Pass-Through) Model Net Rx Claims: 24,368 Ingredient Cost: $2,667,732 Pass-Through: $2,667,732 Administration Fee: $4.00 PBM Makes: $13.32 per claim Total Cost: $2,992,448 24,368 x $4.00 = $97,472 Total Cost: $2,765,204 Savings of $9.32/claim or $227,244

Actual Repricing Data: Same Drug, Same Pharmacy, Same Day Spread Model ProCare Rx (Pass-Through) Model Net Rx Claims: 1.141M Ingredient Cost: $133.37M Spread: $14.5M $14.5M/1.141M= $12.70 PBM Makes: $12.70 per claim Total Cost: $133.37M Net Rx Claims: 1.141M Ingredient Cost: $118.82M Pass-Through: $118.82M Administration Fee: $2.00 1.141M x $2.00 = $2.282M Total Cost: $121.102M Savings of $10.70/claim or $12.268M

My Challenge to Consultants You are losing badly to traditional PBMs Your clients are grossly overpaying for PBM services Figure it out and stop putting your clients in a bad situation Place your clients with a pass-through PBM and take the shell game out of the equation Negotiate a fair administration fee

Rebates - Conceptual High priced brands with higher rebates Lower priced brands with lower rebates Are you driven by highest rebate? Are you driven by lowest net cost? 2 similar brands in terms of efficacy & safety Brand A: $250 with a $75 rebate (net $175) Brand B: $150 with a $10 rebate (net $140)

Formularies - Conceptual Need P&T clinical team to review therapeutic classes for best in class and whether 2 or more drugs within each class are similar in terms of efficacy and safety Let the bidding begin Old examples everyone has heard of: Crestor vs. Lipitor Nexium vs. Prilosec vs. Prevacid vs. Protonix vs. Aciphex

Formularies Continued Have manufacturers compete for a preferred position on formulary to lower net cost for the plan sponsor Set up a benefit plan design to take advantage of appropriate generics Utilize Quantity Limits, Step Therapy Edits, and Prior Authorizations on targeted medications like specialty drugs

PBM-Owned Mail Order & Specialty Pharmacies Pros Control customer service Ability to lower cost Cons Direct from wholesaler vs. a vendor also making profits Incentive to approve medications that should be denied (making money at pharmacy)

What Should Benefit Managers Do? Work with a pass-through PBM Assure the contract states the PBM will pass-through the price they pay for the medications and only earn an administration fee know exactly what you are paying Never sign with a traditional spread model You will overpay for your current mix of medications Insist all fees from brokers/consultants/tpas are disclosed in the contract, or pay those separately don t allow PBM contract to include others fees

What Should Benefit Managers Do? Take advantage of appropriate benefit plan designs Low net cost Appropriate generics (dependent upon evidencebased data) Appropriate denials (dependent upon evidencebased data)

Thank You! John Addelman Chief Sales Officer, ProCare Rx Email: jaddelman@procarerx.com Cell Phone: (813) 220-3904